Linked Life Data

19004363

Source:http://linkedlifedata.com/resource/pubmed/id/19004363

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-11-13
pubmed:abstractText
The clinical practice guidelines of the Drug Commission of the German Medical Association (DCGMA) are intended to provide a solid basis of therapeutic rationality. Being evidence-based and practice-orientated, these guidelines are not supposed to restrict or replace independent and responsible action. The DCGMA board selects the topics with their importance to general practice being a relevant criterion. A multidisciplinary working group comprising DCGMA experts that have no conflict of interest with the pharmaceutical industry is then established. A panel of office-based physicians is involved in the process of establishing consensus. Once the paper is accepted, the respective professional societies are consulted. Finally, the guideline is released by the DCGMA board and distributed via different publications and educational events. DCGMA clinical practice guidelines are developed in consideration of the best available evidence; however, for many questions of pharmacological treatment the evidence remains fragmentary. In addition, there are many points where the results of clinical research, currently often funded by pharmaceutical companies, might not be unbiased.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1865-9217
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
245-52
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Treatment recommendations from the Drug Commission of the German Medical Association].
pubmed:affiliation
Arzneimittelkommission der deutschen Arzteschaft, Berlin.
pubmed:publicationType
Journal Article, English Abstract